Efficacy of STI571, an Abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against Bcr-Abl–positive cells
Year: 2000
Type: article
Source: Blood
Institution: Oregon Health & Science University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
Award: G5307585439
OpenAlex ID: W2269214236
